Reuters logo
BRIEF-Boston Scientific initiates global study to assess sudden cardiac arrest prevention therapy
April 18, 2017 / 8:40 PM / 5 months ago

BRIEF-Boston Scientific initiates global study to assess sudden cardiac arrest prevention therapy

April 18 (Reuters) - Boston Scientific Corp:

* Boston Scientific initiates global study to assess sudden cardiac arrest prevention therapy in patients with diabetes who have previously experienced a heart attack

* Boston Scientific - emblem mri s-icd system has been accepted for parallel review for new indication by fda, centers for medicare & medicaid services

* Boston Scientific Corp- organizations will concurrently review madit s-icd trial data as well as other relevant information to determine fda approval Source text for Eikon: Further company coverage:

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below